12/04/2025 | News release | Distributed by Public on 12/04/2025 15:30
The Centers for Disease Control and Prevention issued an advisory Dec. 3 on an outbreak of Marburg virus in Ethiopia. The agency said a risk of spread to the U.S. is low. In addition, the Administration for Strategic Preparedness and Response announced Dec. 4 that it will provide up to 2,500 doses of the Sabin Vaccine Institute's Marburg vaccine and up to 25 treatment courses of Mapp Biopharmaceutical's monoclonal antibody therapeutic to support Ethiopia's response.